Impact of Hypertension, Aging, and Antihypertensive Treatment on the Morphology of the Pudendal Artery

Journal of Sexual Medicine

Volumn 8, Issue 4, 2011, Pages 1027-1038

  Hannan, Johanna L ^a   Blaser, Mark C ^a   Pang, Judith J ^a   Adams, Stephen M ^a   Pang, Stephen C ^a   Adams, Michael A ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Aging; Antihypertensive Treatment; Hypertension; Internal Pudendal Artery; Vascular Remodeling; Vasculogenic Erectile Dysfunction

Indexed keywords

APOMORPHINE; ENALAPRIL; HYDROCHLOROTHIAZIDE;

ADOLESCENT; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTERIAL INSUFFICIENCY; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ERECTILE DYSFUNCTION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TELEMETRY; WISTAR KYOTO RAT;

EID: 79953300303     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.02191.x     Document Type: Article

References (65)

1. Kannel WB. Risk stratification in hypertension: New insights from the Framingham Study. Am J Hypertens 2000;13:3S-10S.
2. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-9.
3. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
4. Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 2000;342:905-12.
5. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: A risk profile from the Framingham Study. Stroke 1991;22:312-8.
6. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-8.
7. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study. J Urol 2000;163:460.
8. Mallis D, Moisidis K, Kirana PS, Papaharitou S, Simos G, Hatzichristou D. Moderate and severe erectile dysfunction equally affects life satisfaction. J Sex Med 2006;3:442-9.
9. Manolis A, Doumas M. Sexual dysfunction: The 'prima ballerina' of hypertension-related quality-of-life complications. J Hypertens 2008;26:2074-84.
10. Kloner R. Erectile dysfunction and hypertension. Int J Impot Res 2007;19:296-302.
11. Heruti RJ, Sharabi Y, Arbel Y, Shochat T, Swartzon M, Brenner G, Justo D. The prevalence of erectile dysfunction among hypertensive and prehypertensive men aged 25-40 years. J Sex Med 2007;4:596-601.
12. Spessoto LC, Cordeiro JA, de Godoy JM. Effect of systemic arterial pressure on erectile dysfunction in the initial stages of chronic arterial insufficiency. BJU Int 2010;106:1723-5.
13. Jackson G, Montorsi P, Adams MA, Anis T, El-Sakka A, Miner M, Vlachopoulos C, Kim E. Cardiovascular aspects of sexual medicine. J Sex Med 2010;7:(4 Pt 2):1608-26.
14. Cuellar de Leon AJ, Ruiz Garcia V, Campos Gonzalez JC, Perez Hoyos S, Brotons Multo F. Prevalence erectile dysfunction in patients with hypertension. Med Clin (Barc) 2002;119:521-6.
15. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005;47:80-5. discussion 85-6.
16. Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, Simonsen U, Uckert S, Wespes E, Andersson KE, Lue TF, Stief CG. Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med 2010;7(1 Pt 2):445-75.
17. Behr-Roussel D, Gorny D, Mevel K, Compagnie S, Kern P, Sivan V, Bernabe J, Bedigian MP, Alexandre L, Giuliano F. Erectile dysfunction: An early marker for hypertension? A longitudinal study in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2005;288:R276-83.
18. Behr-Roussel D, Chamiot-Clerc P, Bernabe J, Mevel K, Alexandre L, Safar ME, Giuliano F. Erectile dysfunction in spontaneously hypertensive rats: Pathophysiological mechanisms. Am J Physiol Regul Integr Comp Physiol 2003;284:R682-8.
19. Okabe H, Hale TM, Kumon H, Heaton JP, Adams MA. The penis is not protected-In hypertension there are vascular changes in the penis which are similar to those in other vascular beds. Int J Impot Res 1999;11:133-40.
20. Hale TM, Hannan JL, Carrier S, deBlois D, Adams MA. Targeting vascular structure for the treatment of sexual dysfunction. J Sex Med 2009;6(3 suppl):210-20.
21. Falkensammer J, Hakaim AG, Falkensammer CE, Broderick GA, Crook JE, Heckman MG, Oldenburg WA, Hugl B. Prevalence of erectile dysfunction in vascular surgery patients. Vasc Med 2007;12:17-22.
22. Jackson G. Prevention of cardiovascular disease by the early identification of erectile dysfunction. Int J Impot Res 2008;20(2 suppl):S9-14.
23. Bohm M, Baumhakel M, Teo K, Sleight P, Probstfield J, Gao P, Mann JF, Diaz R, Dagenais GR, Jennings GL, Liu L, Jansky P, Yusuf S. ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation 2010;121:1439-46.
24. Salem S, Abdi S, Mehrsai A, Saboury B, Saraji A, Shokohideh V, Pourmand G. Erectile dysfunction severity as a risk predictor for coronary artery disease. J Sex Med 2009;6:3425-32.
25. Guay AT. ED2: Erectile dysfunction = endothelial dysfunction. Endocrinol Metab Clin North Am 2007;36:453-63.
26. Toblli JE, Stella I, Inserra F, Ferder L, Zeller F, Mazza ON. Morphological changes in cavernous tissue in spontaneously hypertensive rats. Am J Hypertens 2000;13:686-92.
27. Manabe K, Heaton JP, Morales A, Kumon H, Adams MA. Pre-penile arteries are dominant in the regulation of penile vascular resistance in the rat. Int J Impot Res 2000;12:183-9.
28. Dusing R. Sexual dysfunction in male patients with hypertension: Influence of antihypertensive drugs. Drugs 2005;65:773-86.
29. Papatsoris AG, Korantzopoulos PG. Hypertension, antihypertensive therapy, and erectile dysfunction. Angiology 2006;57:47.
30. Fogari R, Preti P, Derosa G, Marasi G, Zoppi A, Rinaldi A, Mugellini A. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 2002;58:177-80.
31. Llisterri JL, Lozano Vidal JV, Aznar Vicente J, Argaya Roca M, Pol Bravo C, Sanchez Zamorano MA, Ferrario CM. Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 2001;321:336-41.
32. Hale TM, Okabe H, Bushfield TL, Heaton JP, Adams MA. Recovery of erectile function after brief aggressive antihypertensive therapy. J Urol 2002;168:348-54.
33. Hannan JL, Smallegange C, Hale TM, Heaton JP, Adams MA. Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats. J Hypertens 2006;24:159-68.
34. Toblli JE, Stella I, Mazza ON, Ferder L, Inserra F. Different effect of losartan and amlodipine on penile structures in male spontaneously hypertensive rats. Am J Nephrol 2004;24:614-23.
35. Mazza ON, Angerosa M, Becher E, Toblli JE. Differences between Candesartan and Hydralazine in the protection of penile structures in spontaneously hypertensive rats. J Sex Med 2006;3:604-11.
36. Beharry RK, Hale TM, Heaton JP, Shamloul R, Adams MA. Restoration of female genital vasocongestive arousal responses in young and aged rats. J Sex Med 2008;5:804-12.
37. Hannan JL, Blaser MC, Oldfield L, Pang JJ, Adams SM, Pang SC, Adams MA. Morphological and functional evidence for the contribution of the pudendal artery in aging-induced erectile dysfunction. J Sex Med 2010;7:3373-85.
38. Heaton JP, Varrin SJ, Morales A. The characterization of a bio-assay of erectile function in a rat model. J Urol 1991;145:1099.
39. Shaver SW, Pang JJ, Wainman DS, Wall KM, Gross PM. Morphology and function of capillary networks in subregions of the rat tuber cinereum. Cell Tissue Res 1992;267:437-48.
40. Jiang R, Chen JH, Jin J, Shen W, Li QM. Ultrastructural comparison of penile cavernous tissue between hypertensive and normotensive rats. Int J Impot Res 2005;17:417-23.
41. Smeda JS, Lee RM, Forrest JB. Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension. Circ Res 1988;63:534-42.
42. van Gorp AW, van Ingen Schenau DS, Hoeks AP, Struijker Boudier HA, Reneman RS, De Mey JG. Aortic wall properties in normotensive and hypertensive rats of various ages in vivo. Hypertension 1995;26:363-8.
43. Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res 1982;51:280-9.
44. Warshaw DM, Mulvany MJ, Halpern W. Mechanical and morphological properties of arterial resistance vessels in young and old spontaneously hypertensive rats. Circ Res 1979;45:250-9.
45. Bakircioglu ME, Sievert KD, Nunes L, Lau A, Lin CS, Lue TF. Decreased trabecular smooth muscle and caveolin-1 expression in the penile tissue of aged rats. J Urol 2001;166:734-8.
46. Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Davila HH, Rajfer J, Gonzalez-Cadavid NF. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat. Biol Reprod 2007;76:915-23.
47. Costa C, Vendeira P. Does erectile tissue angioarchitecture modify with aging? An immunohistological and morphometric approach. J Sex Med 2008;5:833-40.
48. Scebat L, Renais J, Groult N. Spontaneous aortic lesions in the rabbit. Possible role of immune mechanisms. Paroi Arterielle 1980;6:37-45.
49. Hoover GA, Nicolosi RJ, Camp RR, Hayes KC. Characteristics of the aortic intima in young and old cebus and squirrel monkeys. Arteriosclerosis 1982;2:252-65.
50. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 1990;10:966-90.
51. Thyberg J, Blomgren K, Hedin U, Dryjski M. Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: An electron-microscopic and stereological study. Cell Tissue Res 1995;281:421-33.
52. Thyberg J, Blomgren K, Roy J, Tran PK, Hedin U. Phenotypic modulation of smooth muscle cells after arterial injury is associated with changes in the distribution of laminin and fibronectin. J Histochem Cytochem 1997;45:837-46.
53. Orlandi A, Bochaton-Piallat ML, Gabbiani G, Spagnoli LG. Aging, smooth muscle cells and vascular pathobiology: Implications for atherosclerosis. Atherosclerosis 2006;188:221-30.
54. Hedin U, Sjolund M, Hultgardh-Nilsson A, Thyberg J. Changes in expression and organization of smooth-muscle-specific alpha-actin during fibronectin-mediated modulation of arterial smooth muscle cell phenotype. Differentiation 1990;44:222-31.
55. Wu X, Zhou Q, Huang L, Sun A, Wang K, Zou Y, Ge J. Ageing-exaggerated proliferation of vascular smooth muscle cells is related to attenuation of Jagged1 expression in endothelial cells. Cardiovasc Res 2008;77:800-8.
56. Stemerman MB, Weinstein R, Rowe JW, Maciag T, Fuhro R, Gardner R. Vascular smooth muscle cell growth kinetics in vivo in aged rats. Proc Natl Acad Sci U S A 1982;79:3863-6.
57. Bochaton-Piallat ML, Gabbiani F, Ropraz P, Gabbiani G. Age influences the replicative activity and the differentiation features of cultured rat aortic smooth muscle cell populations and clones. Arterioscler Thromb 1993;13:1449-55.
58. Clowes AW, Clowes MM. Influence of chronic hypertension on injured and uninjured arteries in spontaneously hypertensive rats. Lab Invest 1980;43:535-41.
59. Jandeleit-Dahm K, Burrell LM, Johnston CI, Koch KM. Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats. J Hypertens 1997;15:643-50.
60. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68:450-6.
61. Powell JS, Muller RK, Baumgartner HR. Suppression of the vascular response to injury: The role of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 1991;17:137B-42B.
62. Barker TA, Massett MP, Korshunov VA, Mohan AM, Kennedy AJ, Berk BC. Angiotensin II type 2 receptor expression after vascular injury: Differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade. Hypertension 2006;48:942-9.
63. Hale TM, Okabe H, Heaton JP, Adams MA. Antihypertensive drugs induce structural remodeling of the penile vasculature. J Urol 2001;166:739-45.
64. Owens GK. Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat. Circ Res 1985;56:525-36.
65. Bravo R, Somoza B, Ruiz-Gayo M, Gonzalez C, Ruilope LM, Fernandez-Alfonso MS. Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats. Hypertension 2001;37:E4-10.